Correction
==========

After the publication of this work \[[@B1]\], we found that there were some mistakes in calculating the percentage of composition in Table 1 ([1](#F1){ref-type="fig"}). Clinicopathologic characteristics of breast cancer subtypes. We are therefore providing the revised Table 1, with the updated data for rows \'Mucinous carcinoma\', \'Metaplastic carcinoma\' and \'Others\'. In the sub-content of Table 1, \'Histological type\', the total number of \'Others\' was corrected from 18 to 16, and the composition of \'Others\' type was slightly changed according to breast cancer subtypes. For IHC-Her2 subtype, the number of \'Others\' was changed from 4 to 3, and 6 cases which were previously unidentified were assigned to corresponding subtypes. One case to IHC-BLBC, 2 cases to IHC-QNBC/5NP and 3 cases to IHC-TNCB. There was no effect on statistical analysis with the correction.
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